Glad the topic switched to Videssa. Maybe some inv
Post# of 1418
(Total Views: 231)
Posted On: 03/10/2022 5:46:04 PM
Glad the topic switched to Videssa. Maybe some investors don't even realize there is more to Todos then Tollovid/vir
Great interview. Quite a need and market for something as simple as a blood test to see if you have cancer. 93% rule in and 98% rule out is excellent numbers.
Global Breast Cancer Diagnostics Market Report 2021: Market is Expected to Reach $7.45 Billion in 2025 at a CAGR of 8% - Long-term Forecast to 2030
The global breast cancer diagnostics market is expected to grow from $4.621 billion in 2020 to $5.466 billion in 2021 at a compound annual growth rate (CAGR) of 18.3%. The market is expected to reach $7.458 billion in 2025 at a CAGR of 8%.
Major players in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, and C. R. Bard Inc.
https://www.globenewswire.com/news-release/20...-2030.html
Market Analysis and Insights: Global Breast Cancer Diagnostics Market
Breast cancer diagnostics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 36.5 billion by 2027 growing at a CAGR of 6.70% in the above-mentioned forecast period. Increasing awareness among the people regarding the benefits of breast cancer diagnostics which will help in enhancing the growth of the market.
https://www.pharmiweb.com/press-release/2022-...by-top-pla
Great interview. Quite a need and market for something as simple as a blood test to see if you have cancer. 93% rule in and 98% rule out is excellent numbers.
Global Breast Cancer Diagnostics Market Report 2021: Market is Expected to Reach $7.45 Billion in 2025 at a CAGR of 8% - Long-term Forecast to 2030
The global breast cancer diagnostics market is expected to grow from $4.621 billion in 2020 to $5.466 billion in 2021 at a compound annual growth rate (CAGR) of 18.3%. The market is expected to reach $7.458 billion in 2025 at a CAGR of 8%.
Major players in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, and C. R. Bard Inc.
https://www.globenewswire.com/news-release/20...-2030.html
Market Analysis and Insights: Global Breast Cancer Diagnostics Market
Breast cancer diagnostics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 36.5 billion by 2027 growing at a CAGR of 6.70% in the above-mentioned forecast period. Increasing awareness among the people regarding the benefits of breast cancer diagnostics which will help in enhancing the growth of the market.
https://www.pharmiweb.com/press-release/2022-...by-top-pla
(2)
(0)